It was recently observed that hypermethylation of cGAS and stimulator of interferon genes (STING), both involved in innate immunity, contributes to the disruption of the STING signaling function and reduces tumor antigenicity, fueling melanoma resistance to T-cell-based anticancer therapies [37]. This evidence concerns the gene STING1 and melanoma.